To test if Ezh2 is required at the early TH1-TFH fate-bifurcation stage in vivo, WT Smarta CD4+ T cells were labeled with cell-trace violet (CTV) and adoptively transferred into congenic recipients, followed by LCMV-Arm infection. The gene discussed is CD4; the disease is infection.